Cargando…
Identification of FGF19 as a prognostic marker and potential driver gene of lung squamous cell carcinomas in Chinese smoking patients
Comprehensive genomic characterizations of lung squamous cell carcinoma (LSCC) have been performed, but the differences between smokers (S-LSCC) and never smokers (NS-LSCC) are not clear, as NS-LSCC could be considered as a different disease from S-LSCC. In this study we delineated genomic alteratio...
Autores principales: | Tan, Qiang, Li, Fan, Wang, Guan, Xia, Weiliang, Li, Ziming, Niu, Xiaomin, Ji, Wenxiang, Yuan, Hong, Xu, Qiang, Luo, Qingquan, Zhang, Jie, Lu, Shun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951296/ https://www.ncbi.nlm.nih.gov/pubmed/26943773 http://dx.doi.org/10.18632/oncotarget.7817 |
Ejemplares similares
-
Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104
por: Li, Fan, et al.
Publicado: (2020) -
FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway
por: Ji, Wenxiang, et al.
Publicado: (2016) -
Erratum: βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum
por: Li, Fan, et al.
Publicado: (2020) -
βKlotho is identified as a target for theranostics in non-small cell lung cancer
por: Li, Fan, et al.
Publicado: (2019) -
βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum
por: Li, Fan, et al.
Publicado: (2023)